Tanya Geist
Surgical · Amherst, NYNPI 1174666945
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 16.1%. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,003 payments — averaging $43.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$7K
- Amgen$6K
- UCB, Inc.$5K
- Amylyx Pharmaceuticals, Inc.$4K
- AstraZeneca$4K
- Genentech USA, Inc.$2K
- plus $15K from 54 others
What the payments were for
- Consulting fees$6,89016%
- Speaking & faculty fees$11,65327%
- Travel & lodging$3,2868%
- Food & beverage$21,03849%
- Education$4511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,318 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UltomirisRavulizumab-Cwvz | 13 | $525,128 |
| Radicava OrsEdaravone | 26 | $363,722 |
| Avonex (4 Pack)Interferon Beta-1a | 35 | $289,499 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 30 | $244,919 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 26 | $171,545 |
| VumerityDiroximel Fumarate | 20 | $168,657 |
| MayzentSiponimod | 18 | $149,906 |
| Glatiramer Acetate | 27 | $57,523 |
| GlatopaGlatiramer Acetate | 15 | $34,445 |
| Nurtec OdtRimegepant Sulfate | 27 | $30,028 |
| NuedextaDextromethorphan Hbr/Quinidine | 14 | $23,510 |
| Aimovig AutoinjectorErenumab-Aooe | 17 | $20,801 |
| Dalfampridine ErDalfampridine | 59 | $18,798 |
| Teriflunomide | 42 | $12,434 |
| Rasagiline Mesylate | 44 | $10,261 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaUltomiris | $4,154 | $525,12813 claims |
| BiogenAvonex (4 Pack), Vumerity | $755 | $458,15555 claims |
| Grifols USA, LLCGamunex-C | $150 | $171,54526 claims |
| NovartisMayzent | $1,065 | $149,90618 claims |
| PfizerNurtec Odt | $273 | $30,02827 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $266 | $23,51014 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide, Mycophenolate Mofetil | $52 | $9,465121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,544 surgical providers in New York.
Other surgical in Amherst
- Wendy CallenAmherst$15K
- Ashley LauricellaAmherst$6K
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Irina KommNew York$39K
- Sarah MartineckWilliamsville$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.